focus -WSS

focus

author：focus 2025-09-27 23:31:48 - browse：497

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

WSS

Continuity nursing helped my family in our darkest PICU moments

Medicare proposal to cover medical devices draws a mixed reaction

The cancer drug shortage isn’t new — and neither are the solutions

Bird flu: Don't repeat Covid's 'health versus the economy' framing

NVIDIA and Google execs on the future of AI and drug discovery

As demand for Covid shots wanes, Moderna seeks its next success

hotspot

focus

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Medical records are filled with copy

Medicare details structure of new drug price negotiation program

Walensky prepares to leave CDC — and Congress — behind

Guidelines to prevent youth baseball injuries need more muscle

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Moonlake's readout produced a cash windfall. Risks remain

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Dobbs anniversary: the lost opportunity of abortion as health care

Military medical care influenced by rank and race, new study finds

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

23andMe had bad news about my health. I wish a person had delivered it

How one medical school became remarkably diverse

Medicare details structure of new drug price negotiation program

Readers respond to H5N1 and livestock movements, and more

It's time to retire 'poor historian' from clinicians' vocabularies

focus

focus

explore

entertainment